TipRanks on MSN
GSK’s New Phase 3 Study on Efimosfermin Alfa: A Potential Game-Changer for Liver Disease Treatment
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A ...
TipRanks on MSN
GSK Advances Share Buyback Program with Recent Purchase
An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 180,000 of its own ordinary shares as part ...
In addition to Goldman Sachs, GlaxoSmithKline also received a Hold from UBS’s Matthew Weston in a report issued yesterday. However, on the same day, Bernstein maintained a Buy rating on ...
The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...
Reversing a policy introduced five years ago after a marketing scandal, GlaxoSmithKline will resume payments to physicians who help promote its drugs next year, according to Bloomberg. 1. The British ...
GlaxoSmithKline Inc. was registered by Chase Tribble, a consultant with Counsel Public Affairs Inc. for a number of lobbying ...
A recent study shows adults with cardiovascular disease (CVD) have a higher risk of developing shingles. People who have two ...
In addition to DZ BANK AG, GlaxoSmithKline also received a Hold from Deutsche Bank ‘s Emmanuel Papadakis in a report issued today. However, yesterday, Bank of America Securities maintained a Sell ...
On October 15, 2024, GSK filed two complaints against Moderna in the District Court for the District of Delaware, asserting that Moderna willfully infringes GSK’s mRNA patent portfolio. In Civil ...
Drug giant GlaxoSmithKline agreed to buy cancer treatment company Tesaro for about $5.1 billion including debt, according to CNBC. The deal gives GlaxoSmithKline access to Tesaro’s ovarian cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback